CD8A and neoplasm: We have previously shown in the BALB/c-derived 4T1 mouse model of immune-checkpoint blockade (ICB)-resistant metastatic breast cancer that tumor-targeted radiation therapy (RT) combined with CTLA-4 blockade induces the CD8+ T cell-mediated regression of irradiated tumors and inhibits lung metastases [2].